{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:00:52Z","timestamp":1784595652126,"version":"3.55.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.lfs.2024.122908","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T17:38:43Z","timestamp":1720978723000},"page":"122908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Unravelling the progress and potential of drug-eluting stents and drug-coated balloons in cardiological insurgencies"],"prefix":"10.1016","volume":"352","author":[{"given":"Yashdeep","family":"Mukheja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankan","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashish","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Vashishth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Kuhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwaljit","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.lfs.2024.122908_bb0005","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2018.02.023","article-title":"Restenosis, stent thrombosis, and bleeding complications: navigating between Scylla and Charybdis","volume":"71","author":"Torrado","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.lfs.2024.122908_bb0010","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147134","article-title":"Integrin alpha9 regulates smooth muscle cell phenotype switching and vascular remodeling","volume":"6","author":"Jain","year":"2021","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.lfs.2024.122908_bb0015","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.121.316021","article-title":"Smooth muscle cell-specific PKM2 (pyruvate kinase muscle 2) promotes smooth muscle cell phenotypic switching and Neointimal hyperplasia","volume":"41","author":"Jain","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI124708","article-title":"Smooth muscle cell-specific fibronectin-EDA mediates phenotypic switching and neointimal hyperplasia","volume":"130","author":"Jain","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.lfs.2024.122908_bb0025","doi-asserted-by":"crossref","first-page":"E1150","DOI":"10.21037\/jtd.2016.10.93","article-title":"Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment","volume":"8","author":"Buccheri","year":"2016","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.98.3.224","article-title":"Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses","volume":"98","author":"Komatsu","year":"1998","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.lfs.2024.122908_bb0035","article-title":"Duration of dual antiplatelet therapy after stent implantation, still an enigma: a systematic review of randomized clinical trials","volume":"13","author":"Aslam Zahid","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.lfs.2024.122908_bb0040","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.4244\/EIJ-D-19-01031","article-title":"Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries","volume":"17","author":"Tamez","year":"2021","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40204-018-0097-y","article-title":"Cardiovascular stents: overview, evolution, and next generation","volume":"7","author":"Borhani","year":"2018","journal-title":"Prog Biomater"},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15420\/ecr.2018:8:2","article-title":"The newest generation of drug-eluting stents and beyond","volume":"13","author":"Lee","year":"2018","journal-title":"European Cardiology Review"},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0055","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijcard.2014.09.143","article-title":"Impact of stent strut design in metallic stents and biodegradable scaffolds","volume":"177","author":"Foin","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0002-8703(92)90742-E","article-title":"Effects of design geometry of intravascular endoprostheses on stenosis rate in normal rabbits","volume":"123","author":"Tominaga","year":"1992","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0735-1097(92)90476-4","article-title":"Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model","volume":"19","author":"Schwartz","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122908_bb0070","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1161\/01.STR.0000190893.74268.fd","article-title":"Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up","volume":"36","author":"Abou-Chebl","year":"2005","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.lfs.2024.122908_bb0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents","volume":"354","author":"Serruys","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-2836(68)80024-5","article-title":"Studies of the binding of actinomycin and related compounds to DNA","volume":"35","author":"Muller","year":"1968","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0085","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/CIRCULATIONAHA.106.621342","article-title":"Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same?","volume":"116","author":"Daemen","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0090","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.76.3.412","article-title":"Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells","volume":"76","author":"Marx","year":"1995","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2005.03.069","article-title":"The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the paclitaxel in-stent controlled elution study (PISCES)","volume":"46","author":"Serruys","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.lfs.2024.122908_bb0105","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.lfs.2024.122908_bb0110","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/hc4201.098056","article-title":"Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up","volume":"104","author":"Sousa","year":"2001","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.lfs.2024.122908_bb0115","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1161\/01.CIR.0000164271.01172.1A","article-title":"Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents","volume":"111","author":"Sousa","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lfs.2024.122908_bb0120","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.0000086926.62288.A6","article-title":"Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions","volume":"108","author":"Colombo","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lfs.2024.122908_bb0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"45","key":"10.1016\/j.lfs.2024.122908_bb0130","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/eurheartj\/ehw343","article-title":"Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-eluting vs. paclitaxel-eluting stents for coronary revascularization (SIRTAX) VERY LATE trial","volume":"37","author":"Yamaji","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.lfs.2024.122908_bb0135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40256-018-0295-y","article-title":"Early and late stent thrombosis in patients with versus without diabetes mellitus following percutaneous coronary intervention with drug-eluting stents: a systematic review and Meta-analysis","volume":"18","author":"Yuan","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2013.10.006","article-title":"Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study","volume":"170","author":"Simsek","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.lfs.2024.122908_bb0145","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/jpm12091378","article-title":"Ultrathin struts drug-eluting stents: a state-of-the-art review","volume":"12","author":"Leone","year":"2022","journal-title":"Journal of Pers. Med."},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ccd.29837","article-title":"Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"99","author":"Schukraft","year":"2022","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"5","key":"10.1016\/j.lfs.2024.122908_bb0155","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.amjcard.2019.05.060","article-title":"Everolimus-eluting versus Biolimus-eluting coronary stent implantation in patients with and without diabetes mellitus","volume":"124","author":"Gyldenkerne","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122908_bb0160","doi-asserted-by":"crossref","first-page":"370","DOI":"10.14740\/cr800","article-title":"Clinical outcomes of World\u2019s thinnest (50 mumr) strut biodegradable polymer coated Everolimus-eluting coronary stent system in real-world patients","volume":"9","author":"Patted","year":"2018","journal-title":"Cardiol Res"},{"issue":"5","key":"10.1016\/j.lfs.2024.122908_bb0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joic.12303","article-title":"Stent coating integrity of durable and biodegradable coated drug eluting stents","volume":"29","author":"Yazdani","year":"2016","journal-title":"J. Interv. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122908_bb0170","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jbm.a.31340","article-title":"Fluorine doping into diamond-like carbon coatings inhibits protein adsorption and platelet activation","volume":"83","author":"Hasebe","year":"2007","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.lfs.2024.122908_bb0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijcard.2016.08.175","article-title":"Differential angioscopic findings of neointimal coverage among first-, second-, and next generation drug-eluting stents","volume":"223","author":"Nakayoshi","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"15","key":"10.1016\/j.lfs.2024.122908_bb0180","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","article-title":"Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent","volume":"59","author":"Meredith","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122908_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/136457002760273340","article-title":"A survey of stent designs","volume":"11","year":"2002","journal-title":"Minim. Invasive Ther. Allied Technol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lfs.2024.122908_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002230","article-title":"Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial","volume":"8","author":"Iqbal","year":"2015","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"10","key":"10.1016\/j.lfs.2024.122908_bb0200","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.112.104059","article-title":"Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the randomized evaluation of Sirolimus-eluting versus Everolimus-eluting stent trial (RESET)","volume":"126","author":"Kimura","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lfs.2024.122908_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/biom12091245","article-title":"Development of biodegradable polymeric stents for the treatment of cardiovascular diseases","volume":"12","author":"Shen","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2024.122908_bb0210","article-title":"Advances in the development of biodegradable coronary stents: a translational perspective","volume":"16","author":"Zong","year":"2022","journal-title":"Mater Today Bio"},{"issue":"10105","key":"10.1016\/j.lfs.2024.122908_bb0215","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.lfs.2024.122908_bb0220","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.jacc.2018.09.019","article-title":"Ultrathin bioresorbable polymer Sirolimus-eluting stents versus thin durable polymer Everolimus-eluting stents","volume":"72","author":"Kandzari","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122908_bb0225","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4244\/EIJ-D-19-01079","article-title":"Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial","volume":"16","author":"Smits","year":"2020","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.31083\/j.rcm.2021.01.225","article-title":"Update on coronary artery bioresorbable vascular scaffolds in percutaneous coronary revascularization","volume":"22","author":"Azzi","year":"2021","journal-title":"Rev. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.lfs.2024.122908_bb0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5603\/CJ.a2019.0018","article-title":"Long-term clinical results of biodegradable vascular scaffold ABSORB BVS\u2122 using the PSP-technique in patients with acute coronary syndrome","volume":"27","author":"Hiczkiewicz","year":"2020","journal-title":"Cardiol. J."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10557-022-07401-4","article-title":"Bioresorbable vascular scaffolds: a dissolving dream?","volume":"37","author":"Chaus","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.lfs.2024.122908_bb0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.msec.2018.04.100","article-title":"Biodegradable stents for coronary artery disease treatment: recent advances and future perspectives","volume":"91","author":"Hu","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jcin.2015.09.008","article-title":"Polymer-free Biolimus A9-coated stents in the treatment of De novo coronary lesions: 4- and 12-month angiographic follow-up and final 5-year clinical outcomes of the prospective, multicenter BioFreedom FIM clinical trial","volume":"9","author":"Costa","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0255","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ccd.29869","article-title":"Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study","volume":"99","author":"Eberli","year":"2022","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcin.2015.09.020","article-title":"A randomized comparison of reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus: the RESERVOIR clinical trial","volume":"9","author":"Romaguera","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0265","doi-asserted-by":"crossref","first-page":"233","DOI":"10.21037\/cdt-22-497","article-title":"Choosing the right treatment for the right lesion, Part II: a narrative review of drug-coated balloon angioplasty and its evolving role in dialysis access maintenance","volume":"13","author":"DePietro","year":"2023","journal-title":"Cardiovasc Diagn Ther"},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.31083\/j.rcm2302042","article-title":"Drug-coated balloon for the management of coronary chronic total occlusions","volume":"23","author":"Sanchez-Jimenez","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"issue":"50","key":"10.1016\/j.lfs.2024.122908_bb0275","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018312","article-title":"The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention","volume":"98","author":"Tang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0280","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jcin.2022.10.049","article-title":"Clinical impact of drug-coated balloon-based percutaneous coronary intervention in patients with multivessel coronary artery disease","volume":"16","author":"Shin","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.lfs.2024.122908_bb0285","first-page":"404","article-title":"Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population","volume":"64","author":"Maggio","year":"2016","journal-title":"Minerva Cardioangiol."},{"key":"10.1016\/j.lfs.2024.122908_bb0290","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2147\/CIA.S389302","article-title":"Influence of stent length on Periprocedural outcomes after primary percutaneous coronary intervention in patients with ST segment elevation myocardial infarction","volume":"17","author":"Chen","year":"2022","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0295","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cvr\/cvq047","article-title":"Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor","volume":"86","author":"Ma","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.lfs.2024.122908_bb0300","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"issue":"20","key":"10.1016\/j.lfs.2024.122908_bb0305","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012639","article-title":"Extended duration of dual-antiplatelet therapy after percutaneous coronary intervention: how long is too long?","volume":"8","author":"Howard","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/hrt.2005.071209","article-title":"Antiplatelet treatment for coronary heart disease","volume":"93","author":"Clappers","year":"2007","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.carrev.2016.07.006","article-title":"Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials","volume":"18","author":"Fanari","year":"2017","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"4","key":"10.1016\/j.lfs.2024.122908_bb0320","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011569","article-title":"Drug-coated balloon for small coronary artery disease in patients with and without high-bleeding risk in the BASKET-SMALL 2 trial","volume":"15","author":"Scheller","year":"2022","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"10150","key":"10.1016\/j.lfs.2024.122908_bb0325","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lfs.2024.122908_bb0330","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ccd.28632","article-title":"Duration of dual antiplatelet therapy in elective drug-coated balloon angioplasty","volume":"96","author":"Corballis","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"10194","key":"10.1016\/j.lfs.2024.122908_bb0335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.lfs.2024.122908_bb0340","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the Femoropopliteal artery of the leg: a systematic review and Meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"24","key":"10.1016\/j.lfs.2024.122908_bb0345","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"issue":"38","key":"10.1016\/j.lfs.2024.122908_bb0350","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1093\/eurheartj\/ehz594","article-title":"Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)","volume":"41","author":"Giacoppo","year":"2020","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.lfs.2024.122908_bb0355","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2019.11.065","article-title":"Survival after coronary revascularization with paclitaxel-coated balloons","volume":"75","author":"Scheller","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.lfs.2024.122908_bb0360","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jcin.2017.06.021","article-title":"The SABRE trial (Sirolimus angioplasty balloon for coronary in-stent restenosis): angiographic results and 1-year clinical outcomes","volume":"10","author":"Verheye","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"issue":"7","key":"10.1016\/j.lfs.2024.122908_bb0365","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jcin.2022.01.012","article-title":"Treatment of coronary de novo lesions by a Sirolimus- or paclitaxel-coated balloon","volume":"15","author":"Ahmad","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"issue":"12","key":"10.1016\/j.lfs.2024.122908_bb0370","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"issue":"10","key":"10.1016\/j.lfs.2024.122908_bb0375","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/clc.20929","article-title":"Long-term outcome of percutaneous coronary intervention: the significance of native coronary artery disease progression","volume":"34","author":"Moulias","year":"2011","journal-title":"Clin. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122908_bb0380","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jcmg.2013.10.010","article-title":"Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study","volume":"7","author":"Xie","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"11","key":"10.1016\/j.lfs.2024.122908_bb0385","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4330\/wjc.v7.i11.776","article-title":"Neoatherosclerosis: coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosis","volume":"7","author":"Komiyama","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.lfs.2024.122908_bb0390","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.carrev.2021.03.008","article-title":"Outcomes with drug-coated balloons vs. drug-eluting stents in small-vessel coronary artery disease","volume":"35","author":"Megaly","year":"2022","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"21","key":"10.1016\/j.lfs.2024.122908_bb0395","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015622","article-title":"Drug-coated balloon versus drug-eluting stent in de novo small coronary vessel disease: a systematic review and meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lfs.2024.122908_bb0400","doi-asserted-by":"crossref","first-page":"6548696","DOI":"10.1155\/2019\/6548696","article-title":"Drug coated balloon-only strategy in De novo lesions of large coronary vessels","volume":"2019","author":"Rosenberg","year":"2019","journal-title":"J. Interv. Cardiol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122908_bb0405","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.lfs.2024.122908_bb0410","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"14","author":"Neumann","year":"2019","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0415","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","article-title":"Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"5","author":"Scheller","year":"2012","journal-title":"JACC Cardiovasc. Interv."},{"issue":"17","key":"10.1016\/j.lfs.2024.122908_bb0420","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention"},{"issue":"21","key":"10.1016\/j.lfs.2024.122908_bb0425","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.lfs.2024.122908_bb0430","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1161\/01.CIR.0000044747.37349.64","article-title":"Cardiology patient pages. Angioplasty versus bypass surgery for coronary artery disease","volume":"106","author":"Michaels","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0435","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12238","article-title":"Photodynamic therapy for the treatment of atherosclerotic plaque: lost in translation?","volume":"35","author":"Jain","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.lfs.2024.122908_bb0440","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fphys.2016.00400","article-title":"Intra-arterial drug and light delivery for photodynamic therapy using Visudyne(R): implication for atherosclerotic plaque treatment","volume":"7","author":"Jain","year":"2016","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0445","doi-asserted-by":"crossref","first-page":"16486","DOI":"10.1038\/s41598-021-95026-2","article-title":"Patient-specific computational simulation of coronary artery bifurcation stenting","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2024.122908_bb0450","first-page":"775","article-title":"Blood flow modeling reveals improved collateral artery performance during the regenerative period in mammalian hearts, Nat","volume":"1","author":"Anbazhakan","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"10439","key":"10.1016\/j.lfs.2024.122908_bb0455","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/S0140-6736(24)00430-6","article-title":"Is intravascular imaging the future of percutaneous coronary intervention?","volume":"403","author":"den Dekker","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2024.122908_bb0460","doi-asserted-by":"crossref","first-page":"S456","DOI":"10.1016\/j.ihj.2018.08.012","article-title":"Imaging during percutaneous coronary intervention for optimizing outcomes","volume":"70","author":"Mehrotra","year":"2018","journal-title":"Indian Heart J."},{"issue":"6","key":"10.1016\/j.lfs.2024.122908_bb0465","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2022.11.045","article-title":"Intravascular imaging during percutaneous coronary intervention: JACC state-of-the-art review","volume":"81","author":"Truesdell","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.lfs.2024.122908_bb0470","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jcin.2020.02.035","article-title":"Safety of revascularization deferral of left main stenosis based on instantaneous wave-free ratio evaluation","volume":"13","author":"Warisawa","year":"2020","journal-title":"Cardiovascular Interventions"},{"issue":"23","key":"10.1016\/j.lfs.2024.122908_bb0475","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.3390\/jcm12237246","article-title":"Rotational Atherectomy, orbital Atherectomy, and intravascular lithotripsy comparison for calcified coronary lesions","volume":"12","author":"Florek","year":"2023","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.lfs.2024.122908_bb0480","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/ccd.30909","article-title":"Fractional flow reserve versus intravascular imaging to guide decision-making for percutaneous coronary intervention in intermediate lesions: a meta-analysis","volume":"102","author":"Liu","year":"2023","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.lfs.2024.122908_bb0485","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005979","article-title":"Instantaneous wave-free ratio derived from coronary computed tomography angiography in evaluation of ischemia-causing coronary stenosis: feasibility and initial clinical research","volume":"96","author":"Ma","year":"2017","journal-title":"Medicine"},{"issue":"15","key":"10.1016\/j.lfs.2024.122908_bb0490","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jacc.2011.11.003","article-title":"Development and validation of a new adenosine-independent index of stenosis severity from coronary wave\u2013intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study","volume":"59","author":"Sen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2024.122908_bb0495","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.actbio.2019.08.042","article-title":"Endothelialization of cardiovascular devices","volume":"99","author":"Jana","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.lfs.2024.122908_bb0500","doi-asserted-by":"crossref","first-page":"1269011","DOI":"10.3389\/fcvm.2023.1269011","article-title":"Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-TIMI 51 trial","volume":"10","author":"Chi","year":"2024","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"2","key":"10.1016\/j.lfs.2024.122908_bb0505","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijcard.2012.03.084","article-title":"Endothelial dysfunction following drug-eluting stent implantation: a systematic review of the literature","volume":"165","author":"Minami","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0510","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41569-019-0234-x","article-title":"Drug-eluting coronary stents: insights from preclinical and pathology studies","volume":"17","author":"Torii","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0515","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cjca.2021.12.001","article-title":"Durable polymer drug eluting stent-induced kounis syndrome and eosinophilia requiring long-term immunosuppression","volume":"38","author":"Boucher","year":"2022","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.lfs.2024.122908_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121742","article-title":"Mathematical modelling of endovascular drug delivery: balloons versus stents","volume":"620","author":"Escuer","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0525","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11095-022-03419-3","article-title":"Modeling dual drug delivery from eluting stents: the influence of non-linear binding competition and non-uniform drug loading","volume":"40","author":"Salvi","year":"2023","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.lfs.2024.122908_bb0530","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/ATVBAHA.123.318450","article-title":"Less is more: developments in nanotechnology for antirestenosis therapies","volume":"43","author":"Trepanier","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122908_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201870027","article-title":"Enabling angioplasty-ready \u201csmart\u201d stents to detect in-stent restenosis and occlusion","volume":"5","author":"Chen","year":"2018","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0540","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajpath.2020.10.001","article-title":"Mechanisms of endothelial regeneration and vascular repair and their application to regenerative medicine","volume":"191","author":"Evans","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122908_bb0545","first-page":"154","article-title":"Contemporary approach to heavily calcified coronary lesions","volume":"14","author":"Dini","year":"2019","journal-title":"Interventional Cardiology Review"},{"issue":"14","key":"10.1016\/j.lfs.2024.122908_bb0550","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.3390\/jcm12144844","article-title":"Current management of highly calcified coronary lesions: an overview of the current status","volume":"12","author":"Caiazzo","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2024.122908_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.947776","article-title":"The factors influencing the efficiency of drug-coated balloons","volume":"9","author":"Cao","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0560","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1097-0304(199701)40:1<109::AID-CCD21>3.0.CO;2-M","article-title":"New concept in coronary angioplasty: dilatation with a helical balloon that allows simultaneous autoperfusion","volume":"40","author":"Gurbel","year":"1997","journal-title":"Cathet. Cardiovasc. Diagn."},{"key":"10.1016\/j.lfs.2024.122908_bb0565","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty","volume":"104","author":"Kleber","year":"2015","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.122908_bb0570","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5495219","article-title":"Clinical outcomes of drug-coated balloon in coronary patients with and without diabetes mellitus: a multicenter, propensity score study","volume":"2021","author":"Pan","year":"2021","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122908_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10370","article-title":"Understudied factors in drug-coated balloon design and evaluation: a biophysical perspective","volume":"8","author":"Shazly","year":"2023","journal-title":"Bioengineering & Translational Medicine"},{"issue":"4","key":"10.1016\/j.lfs.2024.122908_bb0580","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5603\/CJ.a2020.0105","article-title":"Provisional drug-coated balloon treatment guided by physiology on de novo coronary lesion","volume":"28","author":"Shin","year":"2021","journal-title":"Cardiol. J."},{"issue":"12","key":"10.1016\/j.lfs.2024.122908_bb0585","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.carrev.2019.01.010","article-title":"How should we treat heavily calcified coronary artery disease in contemporary practice? From atherectomy to intravascular lithotripsy","volume":"20","author":"Kassimis","year":"2019","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.lfs.2024.122908_bb0590","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2017.08.037","article-title":"Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis","volume":"264","author":"Tzafriri","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2024.122908_bb0595","unstructured":"B.B.M. AG, Coroflex Blue Neo. https:\/\/www.bbraun.co.uk\/en\/products\/b0\/coroflex-blue-neo.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0600","unstructured":"N. Inc, CP Stent\u00ae and Mounted CP Stent\u2122. https:\/\/www.numedforchildren.com\/product\/cp-stentr-and-mounted-cp-stenttm. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0605","series-title":"Flex Master F1 Coronary Stent","author":"A.V.I.D. GMBH","year":"2008"},{"key":"10.1016\/j.lfs.2024.122908_bb0610","unstructured":"L.M.T.C. Ltd, H-Stent\u2122 Coronary Stent System. https:\/\/en.lepumedical.com\/products\/h-stent-coronary-stent-system\/. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0615","unstructured":"B.S. Corp, INNOVA vascular self-expanding Stent. https:\/\/www.bostonscientific.com\/en-US\/products\/stents--vascular\/Innova_Vascular_Self-Expanding_Stent_System.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0620","unstructured":"M. Plc, Integrity Coronary Stent system. https:\/\/europe.medtronic.com\/xd-en\/healthcare-professionals\/products\/cardiovascular\/stents\/resolute-integrity-des.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0625","unstructured":"A.V. Inc, MULTI-LINK 8. https:\/\/www.incathlab.com\/en\/equipment\/13-stents\/94-coronary-balloon-expandable-stents\/64-multi-link-8-ll-coronary-stent-system. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0630","series-title":"NIRxcell CoCr Stent System","author":"M. USA","year":"2015"},{"key":"10.1016\/j.lfs.2024.122908_bb0635","unstructured":"V.C. Ltd, ProZeta. http:\/\/www.vascularconcepts.com\/content\/pages.php?pg=products_prozeta. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0640","unstructured":"B.S. Corp, REBEL Platinum Chromium Coronary Stent System. https:\/\/www.bostonscientific.com\/en-US\/products\/stents--coronary\/rebel-platinum-chromium-coronary-stent-system.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0645","unstructured":"T. GmbH, Yukon CC. https:\/\/translumina.com\/yukon_cc\/. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0650","unstructured":"T. GmbH, Yukon Choice PC. https:\/\/translumina.com\/in\/yukon-choice-pc\/. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0655","unstructured":"B.I.G. Ltd, BioFreedom Drug Coated Stent. https:\/\/www.biosensors.com\/intl\/biofreedom. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0660","unstructured":"B.I.G. Ltd, BioFreedom Ultra. https:\/\/www.biosensors.com\/intl\/biofreedom-ultra. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0665","unstructured":"OrbusNeich, COMBO Dual Therapy Stent. https:\/\/orbusneich.com\/product\/combo-plus-dual-therapy-des\/. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0670","unstructured":"B.B.M. AG, Coroflex\u00ae ISAR NEO. https:\/\/www.bbraun.com\/en\/products\/b1\/coroflex-isar-neo.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0675","unstructured":"S.M.S. Inc, DIRECT RX. https:\/\/www.dicardiology.com\/content\/svelte-medical-systems-announces-ce-mark-certification-direct-rx. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0680","unstructured":"M. Ltd., EluNIR Ridaforolimus Eluting Coronary Stent System. https:\/\/medinol.com\/products\/product-1\/overview\/. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0685","unstructured":"M.L.S.P. Ltd, Evermine 50. https:\/\/www.merillife.com\/medical-devices\/vascular-intervention\/coronary\/stents\/drug-eluting-stents\/evermine-50. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0690","unstructured":"S.M.M.G.C. Ltd, Firehawk Liberty. https:\/\/microport.com\/healthcare-professional\/cardiovascular\/percutaneous-coronary-intervention-1\/firehawk-liberty#. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0695","unstructured":"L.M. GmbH, LimusTrack. https:\/\/www.l2mtech.de\/?page_id=494. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0700","unstructured":"M.L.S.P. Ltd, Metafor Drug Eluting Stent. https:\/\/www.merillife.com\/medical-devices\/vascular-intervention\/coronary\/stents\/drug-eluting-stents\/metafor. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0705","unstructured":"M. Plc, Onyx Frontier Zotarolimus-Eluting Coronary Stent System. https:\/\/www.medtronic.com\/us-en\/healthcare-professionals\/products\/cardiovascular\/stents\/onyx-frontier-des.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0710","unstructured":"B. AG, Orsiro Mission. https:\/\/www.biotronik.com\/en-us\/products\/vi\/coronary\/orsiro-mission. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0715","unstructured":"M. Plc, Resolute Onyx DES - DAPT. https:\/\/www.medtronic.com\/me-en\/healthcare-professionals\/products\/cardiovascular\/stents\/resolute-onyx-des.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0720","unstructured":"S.M.S. Inc, SLENDER IDS. https:\/\/citoday.com\/news\/svelte-medicals-slender-ids-and-direct-rx-bioresorbable-coated-des-systems-approved-by-fda. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0725","unstructured":"B.S. Corp, SYNERGY https:\/\/www.bostonscientific.com\/en-US\/products\/stents--coronary\/bioabsorbable-polymer-stent.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0730","unstructured":"B.S. Corp, SYNERGY XD Stent. https:\/\/www.bostonscientific.com\/en-US\/products\/stents--coronary\/synergy-xd.html. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0735","unstructured":"A. Laboratories, Absorb GT1 Bioresorbable Vascular Scaffold. http:\/\/static.abbottnutrition.com\/absorb.com\/Fact_Sheet_Absorb_AP2942640_RevA.pdf. (Accessed 21 January 2024)."},{"issue":"6","key":"10.1016\/j.lfs.2024.122908_bb0740","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2217\/fca-2020-0042","article-title":"The DESolve\u00ae novolimus bioresorbable scaffold","volume":"17","author":"Demola","year":"2021","journal-title":"Future Cardiol."},{"key":"10.1016\/j.lfs.2024.122908_bb0745","unstructured":"R.M. Inc, Fantom Encore. https:\/\/www.revamedical.com\/why-bioresorbable-seaffolds\/fantom-encore\/. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0750","series-title":"Functionalised Cardiovascular Stents","first-page":"75","article-title":"Fundamentals of bioresorbable stents","author":"Ang","year":"2018"},{"issue":"6","key":"10.1016\/j.lfs.2024.122908_bb0755","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/ccd.30435","article-title":"The bioresorbable magnesium scaffold (Magmaris)\u2014state of the art: from basic concept to clinical application","volume":"100","author":"Rola","year":"2022","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.lfs.2024.122908_bb0760","unstructured":"M.L.S.P. Ltd, MeRes 100. https:\/\/www.merillife.com\/blog\/in-the-news\/meres100-brs-the-first-bioresorbable-vascular-matrix-to-treat-coronary-artery-disease. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0765","unstructured":"C. GmbH, PROLIMUS Biograde. https:\/\/cardiovascularnews.com\/cardionovum-announces-distribution-network-in-57-countries-for-its-drug-eluting-balloons-and-stents\/. (Accessed 21 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0770","unstructured":"E. GmbH, Avant Smart Paclitaxel Eluting PTCA balloon catheter. https:\/\/endocor.com\/news-events\/. (Accessed 22 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0775","unstructured":"L.Y.B.C. Ltd., Bingo Drug eluting Balloon catheter. https:\/\/www.medicalexpo.com\/prod\/liaoning-yinyi-biological-technology\/product-299809-995353.html. (Accessed 22 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0780","unstructured":"E.S.P. Ltd, DEVIOR Sirolimus coated Balloon. https:\/\/www.minvasys.com\/devoir.php. (Accessed 22 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0785","unstructured":"E.T. GmbH, DIOR Paclitaxel-eluting coronary Balloon catheter. https:\/\/eurocor.de\/products\/dior. (Accessed 22 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0790","unstructured":"S.J.M.P.C. Ltd., Emilimus-coated Coronary Balloon Dilatation Catheter. https:\/\/min.news\/en\/tech\/8b2ab659642fbea4d9b98c4f6f56f0e0.html. (Accessed 22 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0795","unstructured":"C. GmbH, RESTORE Drug Eluting Balloon. https:\/\/cardionovum.de\/restore\/. (Accessed 22 January 2024)."},{"key":"10.1016\/j.lfs.2024.122908_bb0800","unstructured":"B.B.M. Inc, SeQuent Please Neo. https:\/\/www.bbraun.com\/en\/products\/b3\/sequent-please-neo.html. (Accessed 22 January 2024)."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524004983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524004983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T13:36:52Z","timestamp":1721914612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524004983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":160,"alternative-id":["S0024320524004983"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122908","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the progress and potential of drug-eluting stents and drug-coated balloons in cardiological insurgencies","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122908"}}